ZOLEDRONIC ACID INJECTION 4 MG
ZOLEDRONIC ACID INJECTION 4 MG bisphosphonic acid Zoledronic Acid Injection 4 mg is a bisphosphonic acid which is an inhibitor of osteoclastic bone resorption. It is indicated for the treatment of hypercalcemia of malignancy .Zometa is indicated for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy. India has many manufacturers who manufacture Zoledronic Acid Injection 4 mg .To know more contact us. 3s corporation is Supplier,Exporter ,Wholesaler for Zoledronic Acid Injection 4 mg in India. SIDE EFFECTS urinating less than usual or not at all; drowsiness, confusion, mood changes, increased thirst, loss of appetite, nausea and vomiting; swelling, weight gain, feeling short of breath; muscle spasms, numb or tingly feeling (especially around your mouth); fever, chills, body aches.
Packaging Type : Plastic Bottle
...moreZoledronic Acid Injection
Zoledronic Acid Injection 4 mg is a bisphosphonic acid which is an inhibitor of osteoclastic bone resorption. It is indicated for the treatment of hypercalcemia of malignancy .Zometa is indicated for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.
Packaging Type : Plastic Bottle
...moreYondelis 1mg Injection
Yondelis 1mg Injection is an anti-tumor drug used in the treatment of adult patients having advanced soft tissue sarcoma. It is highly effective for liposarcoma and leiomyosarcoma patients. Yondelis 1mg Injection in combination with pegylated liposomal doxorubicin (PLD) is indicated for the treatment of patients with relapsed platinum-sensitive ovarian cancer. It is formulated by Zeltia and Johnson under the brand name Yondelis. We are one of the prominent Suppliers and Exporters of Yondelis 1mg Injection from Maharashtra, India. Addtional Information : Import License No. FF-116-15404 for 1 vial, Inclusive of all taxes Beerse, Belgium Imported & Marketed in India by 30, Forjett Street, Mumbai 400036 Each Single use vial contains Trabectedin : 1 mg Reconstituted solution: Reconstitute with 20 ml of sterile water for injection I.P. After reconstitution, 1 ml of solution Contains 0.05 mg Trabectedin. Diluted solution : Refer Instruction for Use and Handling in the package leaflet. Side Effects : Medicines and their possible side effects can affect individual people in different ways. The following are some of the side effects that are known to be associated with this medicine. Just because a side effect is stated here does not mean that all people using this medicine will experience that or any side effect. Disturbances of the gut, such as nausea and vomiting, constipation, diarrhoea, indigestion, abdominal pain. Decrease in the numbers of white blood cells (neutropenia), platelets (thrombocytopenia) or red blood cells (anaemia) in the blood. Fatigue, weakness or loss of strength (asthenia). Loss of appetite and weight loss. Headache. Elevated levels of liver enzymes. Injection site reaction. Dizziness. Problems with the nerves, for example causing changes in sensation such as pins and needles (paraesthesia) or numbness. Shortness of breath (dyspnoea). Pain in muscle or joints (myalgia or arthralgia). Hair loss (alopecia). Fever. Low blood pressure (hypotension). Swollen ankles (peripheral oedema). Difficulty sleeping (insomnia). Inflammation of the lining of the mouth (stomatitis). Bacterial, viral or fungal infections, sometimes serious. Muscle breakdown (rhabdomyolysis).
Dosage : 1mg
Grade : Medicine Grade
Storage : Cool and Dry Place
Form : Liquid
Packaging Type : Glass Bottle
Application : Clinical, hospital etc.
...moreXELODA 500 MG TABLET
XELODA 500 MG TABLET anti-cancer chemotherapy drug. DESCRIPTION Xeloda 500 mg (Capecitabine) is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Xeloda is classified as an ‘antimetabolite’. There are also many cheaper generic medicines available in India as a replacement for Xeloda. What Xeloda Is Used For: Metastatic colon or rectal cancer Metastatic breast cancer How Xeloda Is Given: Taken as a pill by mouth.Take after food (within 30 minutes of a meal) with water. (Usually taken in a divided dose 12 hours apart).Tablets come in 2 sizes; 150mg and 500mg.Do not crush, chew or dissolve tablets.The amount of Xeloda that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule. SIDE EFFECTS Xeloda Side Effects: Diarrhea Hand -foot syndrome (Palmar-plantar erythrodysesthesia or PPE) -skin rash, swelling, redness, pain and/or peeling of the skin on the palms of hands and soles of feet. Usually mild, has started as early as 2 weeks after start of treatment. May require reductions in the dose of the medication. Nausea and vomiting Dermatitis Elevated liver enzymes (increased bilirubin levels) (see liver problems). These Xeloda side effects are less common side effects (occurring in about 10-29%) of patients receiving Xeloda: Poor appetite Abdominal pain Low white blood cell count. (This can put you at increased risk for infection). Low platelet count. (This can put you at increased risk for bleeding). Mouth sores Numbness or tingling of hands or feet Swelling of the feet and ankles Fever Constipation Eye irritation (watery eyes, inflammation of the eyelids, redness). Shortness of breath Headache Chest, back, muscle, joint, bone pain (see pain) Dizziness Insomnia (see sleep disturbances) Dehydration Cough Blood clots. (Blood clots rarely can lead to pulmonary embolus or stroke – potentially life-threatening conditions). Excessive sleepiness, confusion, very rare seizures (see central neurotoxicity). Loss of balance Nail changes, darkening of the skin (see skin reactions) Taste changes
...moreXEFTA XEFTA GEFITINIB 250MG TABLET
Xefta (Gefitinib) 250mg is a prescription drug used to treat patients who had gone through cancer treatments previously and in whom cancer has spread to other parts of the body. Dosage : The recommended dose of Xefta is one 250 mg tablet once a day, taken with or without food. If a dose of Xefta is missed, it should be taken as soon as the patient remembers. If it is less than 12 hours to the next dose, the patient should not take the missed dose. Patients should not take a double dose (two doses at the same time) to make up for a forgotten dose. Where dosing of whole tablets is not possible, such as patients who are only able to swallow liquids, tablets may be administered as a dispersion in water. The tablet should be dropped into half a glass of drinking water (non-carbonated), without crushing, and the glass stirred until the tablet has dispersed (approximately 15 minutes) and the contents subsequently drunk immediately. The glass should be rinsed with a further half glass of water and the contents drunk. The liquid can also be administered via a nasogastric tube. Xefta is not recommended for use in children or adolescents as safety and effectiveness in these patient populations has not been studied. SIDE EFFECTS Most common side effects Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth).
Dosage : 5mg
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
Packaging Size : 10 tablets per strip
...moreXBIRA ABIRATERONE ACETATE 250MG
XBIRA 250mg (Abiraterone Acetate) is a prescription drug used for treating a certain type of prostate cancer that has spread to other parts of the body. XBIRA contains Abiraterone acetate which belongs to a class drugs known as antiandrogens. It stops the body from making testosterone which can slow the growth of prostate cancer. Dosage : The recommended dose of XBIRA tablets is 1000mg (four 250mg tablets) administered orally once daily in combination with Prednisone 5mg administered orally twice daily. XBIRA tablets must be taken on an empty stomach. No food should be consumed for at least 2 hours before the dose of XBIRA tablets is taken and for at least 1 hour after the dose of XBIRA tablets is taken. The tablets should be swallowed whole with water and not to be crushed or chewed. It is highly advisable to administer the drug under strict medical supervision and advice. SIDE EFFECTS Most common side effects are Decreased potassium level in blood, Edema, Increased blood pressure, Urinary tract infection, Diarrhoea
Grade Standard : Medicine Grade
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
Packaging Size : 120 tablets per bottle
...moreVORICONAZOLE TABLET 50 & 200 MG
Voriconazole Tablet 50 & 200 mg is used as antifungal agent .It is indicated for use in patients 12 years of age and older in the treatment of infections such as Invasive Aspergillosis,Esophageal Candidiasis andis also used in disseminated Infections In Skin and infections in Abdomen, Kidney, Bladder Wall, And Wounds. India has many manufacturers who manufacture Voriconazole Tablet 50 & 200 mg.To know more contact us. 3s corporation is Supplier,Exporter ,Wholesaler for Voriconazole Tablet 50 & 200 mg in India. ADDITIONAL INFORMATION Voriconazole Tablet 50 & 200 mg should be taken at least one hour before or after a meal. SIDE EFFECTS sudden behavior changes, problems with thinking or speech; upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); urinating less than usual or not at all; bone pain, swelling; uneven heart rate, chest pain.
Dosage Strength : 5mg
Grade Standard : Medicine Grade
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
Usage : Clinical, hospital etc.
...moreVORICONAZOLE INJECTION 100 & 200 MG
Voriconazole Injection 100 & 200 mg is used as antifungal agent .It is indicated for use in patients 12 years of age and older in the treatment of infections such as Invasive Aspergillosis,Esophageal Candidiasis andis also used in disseminated Infections In Skin and infections in Abdomen, Kidney, Bladder Wall, And Wounds. India has many manufacturers who manufacture Voriconazole Injection 100 & 200 mg .To know more contact us. 3s corporation is Supplier,Exporter ,Wholesaler for Voriconazole Injection 100 & 200 mg in India. SIDE EFFECTS sudden behavior changes, problems with thinking or speech; upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); urinating less than usual or not at all; bone pain, swelling; uneven heart rate, chest pain.
...moreViread HIV Tablets
Viread HIV Tablets are the tablets used for treating chronic hepatitis B virus in 18+ Person. The name of our company surfaces prominently among the trusted Suppliers and Exporters of Viread HIV Tablets from Maharashtra, India. The Viread HIV Tablets that we offer are sourced from the reliable vendors of the market. To cater to the extensive demands of the customers, we are providing Viread HIV Tablets in bulk quantities.
Purity : 90%
Grade Standard : Medicine Grade
Storage : Cool and Dry Place
Form : Tablets
Packaging Type : Plastic Bottle
Application : Clinical, hospital etc.
...moreVINORELBINE INJECTION USP 10 & 50 MG
Vinorelbine InjectionUSP 10 & 50 mg is indicated in combination with cisplatin for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).It is also used as a single agent, for the treatment of patients with metastatic NSCLC. There are many generic manufacturers in India who manufacture Vinorelbine InjectionUSP 10 & 50 mg including fresenius-kabi etc. 3s corporation is Supplier,Exporter ,Wholesaler for Vinorelbine InjectionUSP 10 & 50 mg in India. SIDE EFFECTS HEPATIC TOXICITY Drug-induced liver injury manifest by elevations of aspartate aminotransferase and bilirubin can occur in patients receiving Vinorelbine alone or in combination with cytotoxic agents. SEVERE CONSTIPATION AND BOWEL OBSTRUCTION Severe and fatal paralytic ileus, constipation, intestinal obstruction, necrosis, and perforation occur with Vinorelbine administration. EXTRAVASATION AND TISSUE INJURY Extravasation of Vinorelbine can result in severe irritation, local tissue necrosis and/or thrombophlebitis. NEUROLOGIC TOXICITY Sensory and motor neuropathies, including severe neuropathies, occur in patients receiving Vinorelbine. PULMONARY TOXICITY AND RESPIRATORY FAILURE Pulmonary toxicity, including severe acute bronchospasm, interstitial pneumonitis, acute respiratory distress syndrome (ARDS) occurs with use of Vinorelbine. Interstitial pneumonitis and ARDS included fatalities. The mean time to onset of interstitial pneumonitis and ARDS after Vinorelbine administration was one week (range 3 to 8 days) . EMBRYO-FETAL TOXICITY Vinorelbine can cause fetal harm when administered to a pregnant woman. In animal reproduction studies in mice and rabbits, embryo and fetal toxicity were observed with administration of Vinorelbine at doses approximately 0.33 and 0.18 times the human therapeutic dose, respectively. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, apprise the patient of the potential hazard to a fetus.
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
...moreVINGRAF TACROLIMUS CAPSULE
Vingraf (Tacrolimus) is an immunosuppressant used for organ transplantation. It can be obtained only with prescription. Dosage : KIDNEY TRANSPLANT: In combination with azathioprine: Initial dose:1 mg/kg orally every 12 hours. Initiate within 24 hours of surgery, but delay until renal function has recovered. In combination with mycophenolate mofetil (MMF)/interleukin-2 (IL-2) receptor antagonist: Initial dose:05 mg/kg orally every 12 hours. Initiate within 24 hours of surgery, but delay until renal function has recovered. LIVER TRANSPLANT: Initial dose:05 to 0.075 mg/kg orally every 12 hours. Initiate no sooner than 6 hours after surgery. HEART TRANSPLANT: Initial dose: 0.0375 mg/kg orally every 12 hours. Initiate no sooner than 6 hours after surgery SIDE EFFECTS Most common side effects are Headache, Nausea, Insomnia (difficulty in sleeping), Diarrhoea, Renal dysfunction, Increased glucose level in blood, Tremor.
...moreVFEND 200 MG TABLET
VFEND 200 MG TABLET  prescription drug triazole antifungal medication  Vfend (Voriconazole) manufactured by Pfizer is a prescription drug, triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections. It is available in tablet & injection form both in 50 mg & 200 mg dosage.  ADDITIONAL INFORMATION nstructions for Use in All Patients VFEND Tablets or Oral Suspension should be taken at least one hour before or after a meal. VFEND I.V. for Injection requires reconstitution to 10 mg/mL and subsequent dilution to 5 mg/mL or less prior to administration as an infusion, at a maximum rate of 3 mg/kg per hour over 1 to 2 hours. Do not administer as an IV bolus injection. Use of VFEND I.V. With Other Parenteral Drug Products Blood products and concentrated electrolytes VFEND I.V. must not be infused concomitantly with any blood product or short-term infusion of concentrated electrolytes, even if the two infusions are running in separate intravenous lines (or cannulas). Electrolyte disturbances such as hypokalemia, hypomagnesemia and hypocalcemia should be corrected prior to initiation of VFEND therapy . Intravenous solutions containing (non-concentrated) electrolytes VFEND I.V. can be infused at the same time as other intravenous solutions containing (non-concentrated) electrolytes, but must be infused through a separate line. Total parenteral nutrition (TPN) VFEND I.V. can be infused at the same time as total parenteral nutrition, but must be infused in a separate line. If infused through a multiple-lumen catheter, TPN needs to be administered using a different port from the one used for VFEND I.V. Recommended Dosing in Adults: Invasive aspergillosis and serious fungal infections due to Fusarium spp. and Scedosporium apiospermum See Table 1. Therapy must be initiated with the specified loading dose regimen of intravenous VFEND on Day 1 followed by the recommended maintenance dose regimen. Intravenous treatment should be continued for at least 7 days. Once the patient has clinically improved and can tolerate medication given by mouth, the oral tablet form or oral suspension form of VFEND may be utilized. The recommended oral maintenance dose of 200 mg achieves a voriconazole exposure similar to 3 mg/kg IV; a 300 mg oral dose achieves an exposure similar to 4 mg/kg IV. Switching between the intravenous and oral formulations is appropriate because of the high bioavailability of the oral formulation in adults [see CLINICAL PHARMACOLOGY]. Candidemia in non-neutropenic patients and other deep tissue Candida infections  SIDE EFFECTS sudden behavior changes, problems with thinking or speech; upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); urinating less than usual or not at all; uneven heart rate, chest pain, general ill feeling; or severe skin reaction — fever
Packaging Type : Plastic Bottle
...moreVESANOID 10 MG
VESANOID 10 MG anti-cancer chemotherapy drug Vesanoid is an anti-cancer chemotherapy drug classified under”retinoid. Its generic name is tretinoin Its used to treat acute promyelocytic leukemia (APL, APML) in people who have not responded to other treatments. It is manufactured by Roche & available in India in tablet form of 10 mg dosage. Pack size is of 100 tablets. ADDITIONAL INFORMATION How this drug is given: Tretinoin is given by mouth (in capsule form).One size capsule – 10mg, do not crush chew or dissolve capsules. Protect from light.Take this medication with food.It also is used as a lotion (topical) for patients with acne and certain rashes.The amount of tretinoin you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer you have. Your doctor will determine your dosage and schedule. SIDE EFFECTS Side effects:Important things to remember about the side effects of tretinoin: Most people do not experience all of the side effects listed.Side effects are often predictable in terms of their onset and duration.Side effects are almost always reversible and will go away after treatment is complete.There are many options to help minimize or prevent side effects.There is no relationship between the presence or severity of side effects and the effectiveness of the medication.The following side effects are common (occurring in greater than 30%) for patients taking tretinoin: Typical retinoid toxicity: (symptoms that are similar to those found in patients taking high doses of vitamin A) Headache, fever, dry skin, dry mucous membranes (mouth, nose), bone pain, nausea and vomiting, rash, mouth sores, itching, sweating, eyesight changes.Flu-like symptoms: malaise, chillsBleeding problemsInfectionsSwelling of feet or anklesPain (bone and joint pain, chest discomfort)Abdominal painThe following are less common side effects (occurring in 10-29%) for patients receiving tretinoin: Weight increaseHeart rate irregularities (arrhythmias – see heart problems)FlushingPoor appetiteWeight lossEarache or feeling of fullness in the earsDiarrheaDizzinessConstipationNumbness and tingling in hands and feetAnxietyHeartburnLow blood pressureInsomniaDepressionHigh blood pressureConfusionA very serious side effect that is preventable with proper monitoring and immediate treatment is APL differentiation syndrome. This syndrome is a reaction between the drug and the leukemia. This syndrome produces fever, difficulty breathing, weight gain, lung and heart problems. It is generally treated with high-dose steroids. In most cases, treatment with tretinoin will continue. Be sure to let your health care professional know if you experience fever of 100.5F or 38C, difficulty breathing, or sudden weight gain. The syndrome usually occurs during the first month of treatment, with some cases reported following the first dose.
Storage : Cool and Dry Place
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
Storage : Cool and Dry Place
...moreVelcade 3.5mg Injection
Velcade Injection has a generic name Bortezomib and is classified as a proteasome inhibitor. It is indicated in the treatment and management of multiple myeloma and relapsed mantle cell lymphoma who has received at least one prior therapy. We are a well-known Velcade 3.5 mg Injection Exporter and Supplier in Delhi (India). We ensure safe delivery of our Velcade 3.5 mg Injection in completely sterile and proper packs. Customers can avail them from us in bulk quantities as well. How Velcade Is Given : As an intravenous (into the vein) injection. The amount of Velcade that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule. Side Effects VELCADE (bortezomib) can cause serious side effects, including : Peripheral neuropathy. VELCADE can cause damage to the nerves, a condition called peripheral neuropathy. You may feel muscle weakness, tingling, burning, pain, and loss of feeling in your hands and feet, any of which can be severe. Tell your doctor if you notice any of these symptoms. Your doctor may change the dose and/or schedule of VELCADE or stop it altogether. If you have peripheral neuropathy before starting VELCADE, your doctor could consider giving you VELCADE subcutaneously. Low blood pressure. VELCADE can cause a drop in blood pressure. Tell your doctor if you have low blood pressure, feel dizzy, or feel as though you might faint. If you are taking drugs that lower blood pressure, your medications might need to be adjusted. If you are not drinking enough liquids, your doctor may need to administer IV fluids. Heart problems. Treatment with VELCADE can cause or worsen heart rhythm problems and heart failure. Your doctor may closely monitor you if you have, or are at risk for, heart disease. Tell your doctor if you experience chest pressure or pain, palpitations, swelling of your ankles or feet, or shortness of breath. Lung problems. There have been reports of lung disorders in patients receiving VELCADE. Some of these events have been fatal. Tell your doctor if you experience any cough, shortness of breath, wheezing, or difficulty breathing. Liver problems. If you have liver problems, it can be harder for your body to get rid of VELCADE. VELCADE has caused sudden liver failure in patients who were taking many medications or had other serious medical conditions. Symptoms of liver problems include a yellow discoloration of the eyes and skin (jaundice) and changes in liver enzymes measured in blood tests. Your doctor will closely monitor you if you have liver disease. Posterior reversible encephalopathy syndrome (PRES). There have been reports of a rare, reversible condition involving the brain, called PRES, in patients treated with VELCADE. Patients with PRES can have seizures, high blood pressure, headaches, tiredness, confusion, blindness, or other vision problems. Treatment with VELCADE should be stopped in cases of PRES. Gastrointestinal problems. VELCADE (bortezomib) treatment can cause nausea, vomiting, diarrhea, and constipation. If your symptoms are severe, your doctor may recommend IV fluids and/or medications. Neutropenia (low levels of neutrophils, a type of white blood cell). VELCADE can cause low levels of white blood cells (infection-fighting cells). If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection. Thrombocytopenia (low levels of platelets). VELCADE can cause low levels of platelets (clot-forming cells). If platelets become very low, there is an increased risk of bleeding. Your doctor may recommend a platelet transfusion. You will have regular blood tests to check your cell counts during your treatment with VELCADE. If the number of these cells is very low, your doctor may change the dose and/or schedule of VELCADE. Tumor lysis syndrome (TLS). TLS is a syndrome that causes a chemical imbalance in the blood that could lead to heart and/or kidney problems. TLS can occur with cancer treatments, and your doctor will be monitoring your blood and urine for any signs of this syndrome. If you develop TLS, your doctor will take appropriate steps to treat it. More than 1 in 5 patients (20%) receiving VELCADE have experienced the following side effects: nausea, diarrhea, thrombocytopenia, neutropenia, peripheral neuropathy, fatigue, neuralgia (nerve pain), anemia, leukopenia (low levels of white blood cells), constipation, vomiting, lymphopenia (low levels of a certain type of white blood cells), rash, pyrexia (fever), and anorexia.
...moreVELASOF SOFOSBUVIR (400MG), VELPATASVIR (100MG) TABLET
Dosage : The recommended Velasof dosage is 1 tablet (Velpatasvir 100mg and sofosbuvir 400mg) taken orally daily without or with food. The dosage level is prescribed by your doctor as per your age, current health condition and medical history. Every treatment regimen is designed for 12 to 24 weeks. SIDE EFFECTS Most common side effects are Fatigue, Nausea, Headache, Insomnia (difficulty in sleeping), Anemia.
Packaging Type : Plastic Bottle
Packaging Size : Pack of 28 tablets
...moreVeenat Tablet
Veenat is a prescription drug manufactured by Natco India , used for the treatment of a type of leukemia (chronic myeloid leukemia or cml), gastrointestinal stromal tumors (gists – a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). Veenat may also be used to prevent cancer from growing in patients after surgical removal of gist.
Dosage : 5mg
Storage : Cool and Dry Place
Packaging Type : Plastic Bottle
Storage : Cool and Dry Place
Application : Clinical, hospital etc.
...moreVeenat 400 Mg
VEENAT 400 MG prescription drug Veenat is a prescription drug manufactured by Natco India , used for the treatment of a type of leukemia (chronic myeloid leukemia or cml), gastrointestinal stromal tumors (gists – a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). Veenat may also be used to prevent cancer from growing in patients after surgical removal of gist. ADDITIONAL INFORMATION Mechanism of ActionVeenat works by blocking the action of an abnormal protein that promotes the multiplication of cancer cells. This helps slow or stop the spread of cancer cells. Dosage:Veenat is usually taken once a day. Overdose:symptoms of overdose associated with veenat may include diarrhea, yellowing eyes and skin, stomach pain, fever, swelling, dark urine, change in amount of urine (severe increase or decrease), headache, loss of appetite, unusual bruising or bleeding, unusual tiredness or weakness, vomiting. Precautions & WarningsVeenat should not be taken without consulting your doctor if you have ever had pulmonary fibrosis (scarring of the lungs), or liver or kidney disease, bone marrow problems, low white blood cell levels, or low blood platelet levels or if you have had your thyroid gland removed and if you have a history of swelling (edema) or fluid retention. Drug Interactions The following drugs may interact with veenat: The side effects including the risk of bleeding may be increased by warfarin The risk of veenat’s side effects may be increased by azole antifungals (itraconazole, ketoconazole), ketolide antibiotics (telithromycin), macrolide antibiotics (clarithromycin, erythromycin), nefazodone, or protease inhibitors (ritonavir) Other cancer drugs (tamoxifen), corticosteroids (prednisone), cyclosporine, tacrolimus, cisapride, calcium channel blockers (diltiazem, verapamil), heart rhythm drugs (amiodarone, quinidine), certain diabetes medications (glipizide, pioglitazone, troglitazone), rifampin, st. John’s wort, nsaids (ibuprofen), antidepressants (desipramine, fluoxetine, paroxetine), beta-blockers (propranolol).
Manufacturer : NATCO
Storage : Cool and Dry Place
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
Storage : Cool and Dry Place
...moreImatinib 400 mg Tablets
Imatinib 400 mg Tablets are used for treating certain types of leukemia other cancers of the blood cells. These tablets are also used to treat gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (a tumor that forms under the top layer of skin). Imatinib 400 Mg Tablets falls under the class of medications called protein-tyrosine kinase inhibitors. Manufactured by Natco, these Imatinib 400 Mg Tablets are available in 100 mg & 400 mg tablet pack. Imatinib 400 Mg Tablets help in stopping the spread of cancer cells. Dosage : If doctor has prescribed to take 800 mg of imatinib, then the patient should take 2 of the 400-mg tablets. Do not take 8 of the 100-mg tablets as the coating contains iron. If the patient is unable to swallow these tablets, then these tablets can be diluted into a glass of water or apple juice. Use 50 milliliters (a little less than 2 ounces) of liquid for each 100-mg tablet and 100 milliliters (a little less than 4 ounces) of liquid for each 400-mg tablet. Stir with a spoon until the tablets crumble completely and drink the mixture immediately. Other Information : Pay Mode Terms : T/T (Bank Transfer) Minimum Order Quantity : 100 Pack Port of Dispatch : Mumbai
Storage : Cool and Dry Place
Form : Tablets
Packaging Type : Stripes
Grade Standard : Medicine Grade
...moreVeenat 100 Mg
Veenat is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs),leukemias and other cancers. Cancers are characterized by uncontrolled growth of cells, and leukemia is a specific type of cancer characterized by uncontrolled proliferation of white blood cells SIDE EFFECTS Veenat may decrease the effectiveness of levothyroxine. Side effects the side effects associated with veenat are fluid retention, anxiety, bone pain, constipation, cough, diarrhea, dizziness, gas, hair loss, headache, increased tear production, loss of appetite, muscle cramps, muscle or joint pain, nausea, night sweats, nose and throat irritation, abdominal pain, hemorrsion problems, and yellowing of the eyes or skin. Note: Veenat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Storage : Cool and Dry Place
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
Storage : Cool and Dry Place
...moreVECURONIUM BROMIDE INJECTION 4 MG /10MG
VECURONIUM BROMIDE INJECTION 4 MG /10MG nondepolarizing neuromuscular blocking agent Vecuronium bromide Injection 4 mg /10mg is a nondepolarizing neuromuscular blocking agent of intermediate duration,Vecuronium bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. There are many generic manufacturers in India who manufactureVecuronium bromide Injection 4 mg /10mg including Sun Pharmaceutical Industries Ltd etc. 3s corporation is Supplier,Exporter ,Wholesaler for Vecuronium bromide Injection 4 mg /10mg in India ADDITIONAL INFORMATION Clinicians must use extreme caution to prevent dosing errors when switching between the various vial sizes SIDE EFFECTS The most frequent side effect to nondepolarizing blocking agents as a class consists of an extension of the drug’s pharmacological action beyond the time period needed. This may vary from skeletal muscle weakness to profound and prolonged skeletal muscle paralysis resulting in respiration insufficiency or apnea. Inadequate reversal of the neuromuscular blockade is possible with vecuronium bromide as with all curariform drugs. These side effects are managed by manual or mechanical ventilation until recovery is judged adequate. Little or no increase in intensity of blockade or duration of action with vecuronium bromide is noted from the use of thiobarbiturates, narcotic analgesics, nitrous oxide, or droperidol. The administration of vecuronium bromide has been associated with rare instances of hypersensitivity reactions (bronchospasm, hypotension and/or tachycardia, sometimes associated with acute urticaria or erythema).
...moreVASOPRESSIN INJECTION 20 & 40 IU
Vasopressin Injection 20 & 40 IU is used to control the frequent urination, increased thirst, and loss of water caused by diabetes insipidus. This is a condition that causes the body to lose too much water and become dehydrated. Vasopressin injection is also used to prevent and treat abdominal or stomach distension that occurs after surgery. It is also used in abdominal or stomach roentgenography. There are many generic manufacturers in India who manufacture Vasopressin Injection 20 & 40 IU including Health Biotech Pvt Ltd etc. 3s corporation is Supplier,Exporter ,Wholesaler for Vasopressin Injection 20 & 40 IU in India. SIDE EFFECTS Side Effects include Pallor, Vomiting, nausea, belching, Abdominal cramps, Tremour, pounding headache, vertigo, fluid retention, Hyponatraemia, Hypersensitivity reaction, sweating, Urticaria, gangrene, desire to defecate, arrhythmias, bradycardia, angina, MI and bronchoconstriction.Potentially Fatal: Anaphylaxis; cardiac arrest or shock.
...moreVANCOMYCIN HYDROCHLORIDE INJECTION 500 / 1000 MG
VANCOMYCIN HYDROCHLORIDE INJECTION 500 / 1000 MG tricyclic glycopeptide antibiotic Vancomycin Hydrochloride Injection 500 & 1000 mg is a tricyclic glycopeptide antibiotic derived from Amycolatopsis orientalis .Vancomycin is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. It is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins .Vancomycin is indicated for initial therapy when methicillinresistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly.Vancomycin is effective in the treatment of staphylococcal endocarditis. Its effectiveness has been documented in other infections due to staphylococci, including septicemia ,bone infections, lower respiratory tract infections, skin and skin structure infections. When staphylococcal infections are localized and purulent, antibiotics are used as adjuncts to appropriate surgical measures. India has many manufacturers who manufacture Vancomycin Hydrochloride Injection 500 & 1000 mg .To know more contact us. 3s corporation is Supplier,Exporter ,Wholesaler for Vancomycin Hydrochloride Injection 500 & 1000 mg in India. ADDITIONAL INFORMATION Rapid bolus administration (e.g., over several minutes) may be associated with exaggerated hypotension, including shock, and, rarely,cardiac arrest. Vancomycin should be administered over a period of not less than 60 minutes to avoid rapid-infusion-related reactions. Stopping the infusion usually results in prompt cessation of these reactions. SIDE EFFECTS INFUSION-RELATED EVENTS During or soon after rapid infusion of vancomycin, patients may develop anaphylactoid reactions, including hypotension, wheezing, dyspnea, urticaria. Rapid infusion may also cause flushing of the upper body NEPHROTOXICITY Renal failure, principally manifested by increased serum creatinine or BUN concentrations, especially in patients administered large doses of vancomycin, has been reported rarely. GASTROINTESTINAL Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment . OTOTOXICITY A few dozen cases of hearing loss associated with vancomycin have been reported. Most of these patients had kidney dysfunction or a preexisting hearing loss or were receiving concomitant treatment with an ototoxic drug. PHLEBITIS Inflammation at the injection site has been reported.
Dosage : 5mg
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
...moreURSOFLAK URSODEOXYCHOLIC ACID CAPSULES
Ursofalk ( ursodeoxycholic acid ) contains bile acid, which may have a protective effect on the liver by reducing the absorption of other potentially toxic bile salts. Ursofalk is used to treat liver diseases such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and cystic fibrosis (CF)-related cholestasis. Dosage : During the first 3 months of treatment, you should take Ursofalk Capsules in the morning, at midday and in the evening. As liver function values improve, the total daily dose may be taken once a day in the evening. Most common side effects are Diarrhoea , Itching/pruritus, Urticaria (nettle rash), Allergic reactions, Nausea/vomiting, Sleep disturbance, Pain in the stomach area or in the upper right part of the belly, under the ribs.
Form : Capsules
Storage : Store at temperature below 25º C
Storage : Cool and Dry Place
Form : Tablets / Liquid / Capsules / Powder
Packaging Type : Plastic Bottle
Storage : Cool and Dry Place
Packaging Size : Pack of 100 capsules
...moreULTRAVIST 370 MG
ULTRAVIST 370 MG iodinated contrast agent DESCRIPTION Ultravist® (iopromide) Injection is an iodinated contrast agent indicated for use in ; 1.Intra-arterial Procedures: 300 mg I/mL for cerebral arteriography and peripheral arteriography; 370 mg I/mL for coronary arteriography and left ventriculography, visceral angiography, and aortography. 2. Intravenous Procedures: 240 mg I/mL for peripheral venography; 300 mg I/mL for excretory urography; 300 mg I/mL and 370 mg I/mL for contrast Computed Tomography (CT) of the head and body (intrathoracic, intraabdominal and retroperitoneal regions) for the evaluation of neoplastic and non-neoplastic lesions. The usefulness of contrast enhancement for the investigation of the retrobulbar space and of low grade or infiltrative glioma has not been demonstrated. It is also available in 370 mg dosage 50 & 100 ml.
...moreOpening Hours